4D Molecular Therapeutics
Engineers virus-based gene therapies for eye and lung diseases, led by a late-stage retinal candidate.
$14.67
After-hours close+0.01 (+0.07%)
At close$14.66(−1.68%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.04 | — | — |
| Aug 2026 | −$1.02 | −$1.04 | −2.0% |
| May 2026 | −$0.97 | −$1.01 | −4.1% |
| Mar 2026 | −$0.53 | $0.43 | +181.1% |
| Nov 2025 | −$1.02 | −$1.01 | +1.0% |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | −$1.04 | — | — | $3.5M | — | — |
| Aug 13, 2026 | −$1.02 | −$1.04 | −2.0% | $3.6M | $3.8M | +4.4% |
| May 7, 2026 | −$0.97 | −$1.01 | −4.1% | $2.6M | $3.0M | +17.8% |
| Mar 18, 2026 | −$0.53 | $0.43 | +181.1% | $27.0M | $85.1M | +215.2% |
| Nov 10, 2025 | −$1.02 | −$1.01 | +1.0% | $30.9M | $90.0K | −99.7% |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 8, 2025 | ||||||
| Feb 28, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 9, 2024 | ||||||
| Feb 29, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Aug 9, 2023 | ||||||
| May 10, 2023 | ||||||
| Mar 15, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 11, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 28, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 13, 2021 | ||||||
| Mar 25, 2021 | ||||||
| Dec 16, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Sep 30, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||